M. Dubroeucq

发表

"Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Archives internationales de pharmacodynamie et de therapie.

PK 11195, an antagonist of peripheral type benzodiazepine receptors, modulates Bay K8644 sensitive but not beta- or H2-receptor sensitive voltage operated calcium channels in the guinea pig heart.

G. Néliat, G. Le Fur, A. Uzan, 1986, Life sciences.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

J. Bénavidès, P. Rufat, G. Le Fur, 1983, Life sciences.

Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

J. Bénavidès, G. Fur, P. Rufat, 1984, European journal of pharmacology.

Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195

M. Desban, J. Bénavidès, G. Fur, 1984, Brain Research Bulletin.

PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog.

G. Fur, G. Bouétard, G. Le Fur, 1985, European journal of pharmacology.

Synthesis and pharmacological properties of 5H,10H‐imidazo[1,2‐a]indeno[1,2‐e]pyrazine‐4‐one, a new competitive AMPA/KA receptor antagonist

A. Imperato, S. Mignani, G. Böhme, 1999 .

Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors.

J. Bénavidès, G. Le Fur, A. Uzan, 1984, Life sciences.

Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.

A. Imperato, F. Petitet, M. Dubroeucq, 1998, Life sciences.

Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

Partial purification and pharmacology of peripheral-type benzodiazepine receptors.

G. Le Fur, A. Uzan, F. Bégassat, 1987, Journal of receptor research.

Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Life sciences.

RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat.

L. Fitzpatrick, C. Pendley, M. Dubroeucq, 1995, The Journal of pharmacology and experimental therapeutics.

Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

G. Fur, A. Uzan, C. Malgouris, 1983, Journal of neurochemistry.

Photoaffinity labeling of peripheral-type benzodiazepine-binding sites.

G. Le Fur, A. Uzan, C. Renault, 1987, Molecular pharmacology.

The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives

A. Uzan, F. Imbault, C. Renault, 1984, Neuropharmacology.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies.

G. Le Fur, A. Uzan, F. Imbault, 1983, Life sciences.

Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.

A. Uzan, C. Renault, M. Dubroeucq, 1986, European journal of pharmacology.

Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.

A. Uzan, C. Renault, M. Dubroeucq, 1984, Archives internationales de pharmacodynamie et de therapie.

Pharmacology of peripheral type benzodiazepine receptors in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Progress in clinical and biological research.